Related Experiment Video
Updated: Aug 13, 2026
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
[Human gene therapy for lung cancer]
T Fujiwara1, F Inoue, N Tanaka
1First Department of Surgery, Okayama University Medical School.
Abstract:
Lung cancer is one of the leading causes of cancer death in the world. The high mortality rate for lung cancer results from the absence of standard therapeutic strategies. Recent advances in molecular biology have demonstrated that multistep genetic alterations are involved in the carcinogenesis of human lung cancer. Human gene therapy has become a reality with the development of effective techniques for delivering the gene to the target cells. The efficacy of gene therapy for various types of genetic disease now being evaluated in clinical trials. These findings led us to develop a novel gene therapeutic strategy for human lung cancer that could either inhibit the oncogene expression or replace the tumor suppressor gene by using recombinant, replication-defective viral vectors. The article reviews recent highlights in this rapidly evolving field.
Insights
Gene therapy offers a new strategy for treating lung cancer by targeting genetic alterations. This approach aims to inhibit oncogenes or replace tumor suppressor genes, potentially improving outcomes for this deadly disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Lung cancer remains a leading cause of cancer mortality globally.
- Current therapeutic strategies for lung cancer lack standardization, contributing to high mortality rates.
- Multistep genetic alterations are recognized as key drivers in human lung cancer development.
Purpose:
- To review recent advancements in gene therapy for human lung cancer.
- To explore novel gene therapeutic strategies utilizing recombinant viral vectors.
- To discuss methods for inhibiting oncogene expression or replacing tumor suppressor genes.
Summary:
- Human gene therapy is advancing, with effective gene delivery techniques now available.
- Recombinant, replication-defective viral vectors are proposed for lung cancer gene therapy.
- The strategy involves targeting specific genetic alterations, including oncogenes and tumor suppressor genes.
Impact:
- Gene therapy presents a promising new avenue for lung cancer treatment.
- This approach could lead to more effective and targeted therapies for lung cancer patients.
- Further clinical evaluation of gene therapy is crucial for its integration into standard care.
More Related Videos
Related Concept Videos
00:59Gene Therapy
00:59Gene Therapy